Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C8H11NO2 |
| Molecular Weight | 153.1784 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC[C@H](O)C1=CC=C(O)C=C1
InChI
InChIKey=QHGUCRYDKWKLMG-QMMMGPOBSA-N
InChI=1S/C8H11NO2/c9-5-8(11)6-1-3-7(10)4-2-6/h1-4,8,10-11H,5,9H2/t8-/m0/s1
| Molecular Formula | C8H11NO2 |
| Molecular Weight | 153.1784 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
(-)-octopamine is an enantiomer of octopamine, a naturally occurring phenolamine acting as a neurotransmitter in invertebrates. Octopamine is considered to be trace amine present in mammalian tissues at very low (nanomolar) concentrations. Generally, the (-)-enantiomers of octopamine are more active than the (+)-enantiomers at adrenergic receptors. However (+)-octopamine is more potent than the (-)-octopamine as an inhibitor of semicarbazide-sensitive amine oxidase.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14221151
Curator's Comment: Preparation of optical isomers of octopamine was performed by Kappe and Armstrong in 1964. The natural occurrence of octopamine was first reported by Erspamer (1952) who identified it as a constituent of extracts of salivary glands of the octopus. https://www.ncbi.nlm.nih.gov/pubmed/14919575
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL1867 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9313925 |
|||
Target ID: CHEMBL1907610 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2833972 |
2.45 null [pIC50] | ||
Target ID: CHEMBL2093864 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2833972 |
4.62 null [pIC50] | ||
Target ID: CHEMBL2095166 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2890747 |
|||
Target ID: CHEMBL4592 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2719723 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Selective inhibition of adenylyl cyclase by octopamine via a human cloned alpha 2A-adrenoceptor. | 1997-09 |
|
| Semicarbazide-sensitive amine oxidase (SSAO) of the rat aorta. Interactions with some naturally occurring amines and their structural analogues. | 1989-05-01 |
|
| Activities of octopamine and synephrine stereoisomers on alpha-adrenoceptors. | 1988-02 |
|
| Beta-adrenergic activities of octopamine and synephrine stereoisomers on guinea-pig atria and trachea. | 1987-09 |
|
| PREPARATION OF D- AND L-OCTOPAMINE. | 1964-07 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9313925
The phenolamines, octopamine and synephrine were only able to couple the alpha 2A-adrenoceptor to a dose-dependent decrease in cyclic AMP production at concentrations up to 1 mM, with the synephrine isomers being more potent than the corresponding octopamine isomers. The meta-isomers of both phenolamines were more potent than the corresponding para-isomers and the (-)-enantiomers were more potent than the (+)-enantiomers. Thus, (-)-meta-synephrine [(-)-phenylephrine] was the most effective isomer tested with an observable decrease occurring between 100 nM and 1 microM.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:37:22 GMT 2025
by
admin
on
Mon Mar 31 22:37:22 GMT 2025
|
| Record UNII |
H1P36W1J84
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
H1P36W1J84
Created by
admin on Mon Mar 31 22:37:22 GMT 2025 , Edited by admin on Mon Mar 31 22:37:22 GMT 2025
|
PRIMARY | |||
|
876-04-0
Created by
admin on Mon Mar 31 22:37:22 GMT 2025 , Edited by admin on Mon Mar 31 22:37:22 GMT 2025
|
PRIMARY | |||
|
440266
Created by
admin on Mon Mar 31 22:37:22 GMT 2025 , Edited by admin on Mon Mar 31 22:37:22 GMT 2025
|
PRIMARY | |||
|
DTXSID901317465
Created by
admin on Mon Mar 31 22:37:22 GMT 2025 , Edited by admin on Mon Mar 31 22:37:22 GMT 2025
|
PRIMARY | |||
|
m8118
Created by
admin on Mon Mar 31 22:37:22 GMT 2025 , Edited by admin on Mon Mar 31 22:37:22 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
RACEMATE -> ENANTIOMER |